Literature DB >> 2715498

Impaired venous return causes circulatory failure in experimental pancreatitic shock in dogs.

O J Rämä1, P Rämö, M Karhunen, H Kiviniemi, R Kettunen.   

Abstract

The haemodynamic effects in the early phase of canine acute experimental pancreatitis (AP) were studied using a cardiac catheterization technique. AP was induced in anaesthetized dogs with an infusion of trypsin-sodium-taurocholate into the pancreatic duct. The initial haemodynamic measurements were performed after the preparation of the animal and 5 min after the induction of AP. Thereafter, pressure and volume parameters were measured at 10 min intervals. AP induced significant increases in heart rate, dP/dtmax and mean arterial pressure, but a decrease in Vmax 5 min after the induction of AP. After the initial phase, the heart rate remained significantly increased, while constant and significant decreases of stroke volume, cardiac output, end-diastolic volume and end-diastolic pressure developed. The parameters of the contractility of the left ventricle were not affected to the same extent. It is suggested that the circulatory failure observed in AP, characterised by a prompt reduction of cardiac output, was primarily due to a heavy reduction in preload. This supports the theory that cardiac output is primarily affected by impaired venous return with consequently decreased preload rather than by a loss of ventricular contractility. Hence, the existence of a myocardial depressant factor in the early phase of experimental AP does not gain support from the present results.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2715498     DOI: 10.1007/BF00295987

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  17 in total

1.  THE NATURE OF THE MECHANISM OF THE SHOCK PRODUCED BY THE INJECTION OF TRYPSIN AND THROMBIN.

Authors:  H J Tagnon
Journal:  J Clin Invest       Date:  1945-01       Impact factor: 14.808

2.  The automatic computation of pressure-derived maximal shortening velocity (Vmax) of the unloaded contractile element in the intact canine heart left ventricle.

Authors:  R Kettunen; J Timisjärvi; E Kouvalainen; P Rämö; M Linnaluoto
Journal:  Acta Physiol Scand       Date:  1986-08

3.  Influence of acute pancreatitis on central hemodynamic, regional blood flow distribution and arteriovenous shunting in the dog.

Authors:  K Wulff; B Sjöström
Journal:  Eur Surg Res       Date:  1974       Impact factor: 1.745

4.  Low molecular weight dextran in experimental pancreatitis.

Authors:  L C Carey
Journal:  Am J Surg       Date:  1970-02       Impact factor: 2.565

5.  A digital filter for the QRS complex detection.

Authors:  M Okada
Journal:  IEEE Trans Biomed Eng       Date:  1979-12       Impact factor: 4.538

6.  Presence of a myocardial depressant factor in patients in circulatory shock.

Authors:  W L Lovett; S L Wangensteen; T M Glenn; A M Lefer
Journal:  Surgery       Date:  1971-08       Impact factor: 3.982

7.  Hemodynamic consequences of severe pancreatitis.

Authors:  E L Bradley; J R Hall; J Lutz; L Hamner; O Lattouf
Journal:  Ann Surg       Date:  1983-08       Impact factor: 12.969

8.  A comparison of digital algorithms used in computing the derivative of left ventricular pressure.

Authors:  A E Marble; C M McIntyre; R Hastings-James; C W Hor
Journal:  IEEE Trans Biomed Eng       Date:  1981-07       Impact factor: 4.538

9.  Circulatory changes in acute pancreatitis.

Authors:  M C Anderson; F B Schoenfeld; W B Iams; M Suwa
Journal:  Surg Clin North Am       Date:  1967-02       Impact factor: 2.741

10.  The myocardial depressant factor (MDF) in acute hemorrhagic pancreatitis.

Authors:  K Ito; G Ramirez-Schon; P M Shah; L R DelGuercio; B M Reynolds
Journal:  Trans Am Soc Artif Intern Organs       Date:  1980
View more
  1 in total

1.  Noninvasive monitoring of hemodynamic changes in acute pancreatitis in rabbits.

Authors:  M Gyöngyösi; T Takács; L Czakó; Z Jambrik; K Boda; A Farkas; T Forster; M Csanády
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.